Precision Medicine

GenomeWeb and Oracle Health Sciences reveal key survey results; WuXi NextCODE and Google Cloud partner; and 2bPrecise and The Innovation Institute collaborate on pharmacogenomics.

But experts from IEEE, UC San Diego and Health Linkages say the key is to make sure it's the "right solution for the right problem."

Company highlights advancements in genomics at St. Jude Children’s Research Hospital, awards partnerships that are leveraging cutting-edge tech.

As the agency works to advance an array of big projects, ONC is also focused on reducing documentation and quality reporting burdens for providers.

Interoperability and the unwillingness of organizations to share information is standing in its way, experts say.

Its new risk score harnesses clinically-validated information from non-clinical settings, enabling health systems to better manage their 30-day readmission risks.

Actionable insights and intelligent health care experiences lead to personalized care and improved operations for providers.

Helix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics. The San Carlos, California-based startup launched the Helix marketplace in July 2017 to collects and sequence a DNA sample once, and then store and protects a customer’s data so they can access additional DNA-powered products and services from the Helix store without providing another saliva sample. [Also: 23andMe lands $250 million to expand do-it-yourself genetics testing] Helix CEO Robin Thurston said the financing will enable it to expand its health-related product offerings as it competes with other genetics companies, such as 23andMe and AncestryDNA. Thurston added that Helix also works with research partners such as the Healthy Nevada Project on community health projects built on Helix Exome platform. The Helix store includes 35 products from 20 partners and that number is expected to grow to more 50 products in 2018 with major launches including new products from partners such as Mayo Clinic. [Also: Microsoft, Google invest in precision medicine startup DNAnexus] Helix has sealed deals with 47 companies to run tests on the Helix platform. Tests are available for $20 and others cost hundreds of dollars. DFJ Growth, with participation from all its founding investors, which include Illumina, Kleiner Perkins Caufield Byers, Mayo Clinic, Sutter Hill Ventures, and Warburg Pincus, led the funding round. Barry Schuler, Partner at DFJ Growth and former chairman and CEO of America Online, will join the Helix Board of Directors. Twitter: @Bernie_HITN Email the writer: bernie.monegain@himssmedia.com

The new partnership aims to enable integration of genomic data across the EHR, making it easier for physicians to order specific tests for personalized medicine.

The technology could enable researchers to test drugs or treatments on a patient’s cells to avoid harmful, ineffective and costly options while determining personalized regimens.